Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.

Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.
复制标题

DOI:
10.4049/jimmunol.1300895
复制
发表时间:
2013-09-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Vancurova I
Vancurova I
中科院分区:
其他
文献类型:
--
作者:
Manna S;Singha B;Phyo SA;Gatla HR;Chang TP;Sanacora S;Ramaswami S;Vancurova I

文献摘要

参考文献

被引文献

相似文献

受NFκB转录水平调控的促炎性和促血管生成趋化因子白介素-8 (IL-8)的表达在雄激素非依赖型转移性前列腺癌中组成性升高,并与不良预后相关。抑制nf κ b依赖性转录被用作抗癌策略,用于开发第一个临床批准的26S蛋白酶体抑制剂硼替佐米(BZ)。尽管BZ在血液系统恶性肿瘤中显示出显著的抗肿瘤活性,但在前列腺癌和其他实体肿瘤中效果较差;然而,其机制尚未被完全理解。本研究报告BZ对蛋白酶体的抑制意外地增加了雄激素非依赖性前列腺癌PC3和DU145细胞中IL-8的表达,而其他nf κ b调节基因的表达被抑制或不变。bz增加的IL-8表达与体外p65 NFκB DNA结合活性增加和p65募集到内源性IL-8启动子有关。此外,蛋白酶体抑制诱导了IKKα的核积累,IKKα酶活性的抑制显著减弱了bz诱导的p65对IL-8启动子的募集和IL-8的表达,表明诱导的IL-8表达至少部分是由IKKα介导的。总之,这些数据为前列腺癌细胞中蛋白酶体抑制IL-8表达的基因特异性增加提供了第一个证据,表明同时靶向IKKα和蛋白酶体可能提高BZ在雄激素非依赖型前列腺癌治疗中的有效性。
Expression of the pro-inflammatory and pro-angiogenic chemokine interleukin-8 (IL-8), which is regulated at the transcriptional level by NFκB, is constitutively increased in the androgen independent metastatic prostate cancer and correlates with poor prognosis. Inhibition of NFκB-dependent transcription was used as an anti-cancer strategy for the development of the first clinically approved 26S proteasome inhibitor, bortezomib (BZ). Even though BZ has shown remarkable anti-tumor activity in hematological malignancies, it has been less effective in prostate cancer and other solid tumors; however, the mechanisms have not been fully understood. Here we report that the proteasome inhibition by BZ unexpectedly increases the IL-8 expression in androgen independent prostate cancer PC3 and DU145 cells, while expression of other NFκB-regulated genes is inhibited or unchanged. The BZ-increased IL-8 expression is associated with increased in vitro p65 NFκB DNA binding activity and p65 recruitment to the endogenous IL-8 promoter. In addition, proteasome inhibition induces a nuclear accumulation of IKKα and inhibition of IKKα enzymatic activity significantly attenuates the BZ-induced p65 recruitment to IL-8 promoter and IL-8 expression, demonstrating that the induced IL-8 expression is mediated, at least partly, by IKKα. Together, these data provide the first evidence for the gene specific increase of IL-8 expression by the proteasome inhibition in prostate cancer cells and suggest that targeting both IKKα and the proteasome may increase the BZ effectiveness in androgen independent prostate cancer treatment.
DOI: 10.1074/jbc.m601350200
发表时间: 2006-08-04
影响因子: 4.8
作者:
Dolcet, Xavier;Llobet, David;Matias-Guiu, Xavier
通讯作者: Matias-Guiu, Xavier
DOI: 10.1016/j.bcp.2009.10.006
发表时间: 2010-03-01
影响因子: 5.8
作者:
Cullen, Sarah J.;Ponnappan, Subramaniam;Ponnappan, Usha
通讯作者: Ponnappan, Usha
DOI: 10.1038/sj.cdd.4401592
发表时间: 2005-05-01
影响因子: 12.4
作者:
Demarchi, F;Bertoli, C;Schneider, C
通讯作者: Schneider, C
DOI: 10.1128/mcb.26.2.457-471.2006
发表时间: 2006-01-01
影响因子: 5.3
作者:
Hoberg, JE;Popko, AE;Mayo, MW
通讯作者: Mayo, MW
DOI: 10.1038/sj.onc.1207705
发表时间: 2004-07-08
期刊: ONCOGENE
影响因子: 8
作者:
Broemer, M;Krappmann, D;Scheidereit, C
通讯作者: Scheidereit, C